GlucoTrack
GCTK
4 hedge funds and large institutions have $743K invested in GlucoTrack in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.
3,915% more capital invested
Capital invested by funds: $18.5K → $743K (+$724K)
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
33% more funds holding
Funds holding: 3 → 4 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.22M |
| 2 |
AF
Alerus Financial
Grand Forks,
North Dakota
|
+$35.9K |
| 3 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$18K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$10.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boston Financial Management
Boston,
Massachusetts
|
-$8.97K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.62K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $702K | +$1.22M | +339 | New |
|
|
AF
2
Alerus Financial
Grand Forks,
North Dakota
| $23.9K | +$35.9K | +10 | +500% |
|
|
WAM
3
Warberg Asset Management
Winnetka,
Illinois
| $10.4K | +$18K | +5 | New |
|
|
TSS
4
Two Sigma Securities
New York
| $6.57K | +$10.8K | +3 | New |
|
5
UBS Group
Zurich,
Switzerland
| $276 | – | – | – |
|
|
BFM
6
Boston Financial Management
Boston,
Massachusetts
| – | -$8.97K | -4 | Closed |
|
|
7
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$5.62K | -3 | Closed |
|
GCTK Hedge Fund Activity: Q2 2023 in Review
4 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q2 2023, worth a combined $743K — up 3,915% from $18.5K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GCTK positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.22M. The largest seller was Boston Financial Management, exiting entirely with an estimated $8.97K sold.
- 4 institutional investors held GlucoTrack (GCTK) as of Q2 2023, up from 3 in Q1 2023.
- Funds reported $743K of GlucoTrack stock for Q2 2023, up 3,915% quarter-over-quarter.
- 3 funds opened new GlucoTrack positions in Q2 2023 and 2 closed out, a net change of +1 holder.
- The largest GlucoTrack buyer in Q2 2023 was Sabby Management, an estimated $1.22M added.
- The largest GlucoTrack seller in Q2 2023 was Boston Financial Management, an estimated $8.97K sold.
Based on aggregated 13F filings for Q2 2023.